Impact of mismatches in HbA 1c vs glucose values on the diagnostic classification of diabetes and prediabetes
- PMID: 31721287
- DOI: 10.1111/dme.14181
Impact of mismatches in HbA 1c vs glucose values on the diagnostic classification of diabetes and prediabetes
Abstract
Aims: To determine whether HbA1c mismatches (HbA1c levels that are higher or lower than expected for the average glucose levels in different individuals) could lead to errors if diagnostic classification is based only on HbA1c levels.
Methods: In a cross-sectional study, 3106 participants without known diabetes underwent a 75-g oral glucose tolerance test (fasting glucose and 2-h glucose) and a 50-g glucose challenge test (1-h glucose) on separate days. They were classified by oral glucose tolerance test results as having: normal glucose metabolism; prediabetes; or diabetes. Predicted HbA1c was determined from the linear regression modelling the relationship between observed HbA1c and average glucose (mean of fasting glucose and 2-h glucose from the oral glucose tolerance test, and 1-h glucose from the glucose challenge test) within oral glucose tolerance test groups. The haemoglobin glycation index was calculated as [observed - predicted HbA1c ], and divided into low, intermediate and high haemoglobin glycation index mismatch tertiles.
Results: Those participants with higher mismatches were more likely to be black, to be men, to be older, and to have higher BMI (all P<0.001). Using oral glucose tolerance test criteria, the distribution of normal glucose metabolism, prediabetes and diabetes was similar across mismatch tertiles; however, using HbA1c criteria, the participants with low mismatches were classified as 97% normal glucose metabolism, 3% prediabetes and 0% diabetes, i.e. mostly normal, while those with high mismatches were classified as 13% normal glucose metabolism, 77% prediabetes and 10% diabetes, i.e. mostly abnormal (P<0.001).
Conclusions: Measuring only HbA1c could lead to under-diagnosis in people with low mismatches and over-diagnosis in those with high mismatches. Additional oral glucose tolerance tests and/or fasting glucose testing to complement HbA1c in diagnostic classification should be performed in most individuals.
Published 2019. This article is a U.S. Government work and is in the public domain in the USA.
Similar articles
-
Implications of the Hemoglobin Glycation Index on the Diagnosis of Prediabetes and Diabetes.J Clin Endocrinol Metab. 2020 Mar 1;105(3):e130-8. doi: 10.1210/clinem/dgaa029. J Clin Endocrinol Metab. 2020. PMID: 31965161 Free PMC article. Clinical Trial.
-
Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.JAMA Pediatr. 2020 Feb 1;174(2):e194498. doi: 10.1001/jamapediatrics.2019.4498. Epub 2020 Feb 3. JAMA Pediatr. 2020. PMID: 31790544 Free PMC article.
-
Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting.Prim Care Diabetes. 2017 Apr;11(2):119-131. doi: 10.1016/j.pcd.2017.01.004. Epub 2017 Jan 26. Prim Care Diabetes. 2017. PMID: 28132763
-
Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.BMC Endocr Disord. 2019 Feb 15;19(1):23. doi: 10.1186/s12902-019-0339-6. BMC Endocr Disord. 2019. PMID: 30770743 Free PMC article.
-
Review of methods for detecting glycemic disorders.Diabetes Res Clin Pract. 2020 Jul;165:108233. doi: 10.1016/j.diabres.2020.108233. Epub 2020 Jun 1. Diabetes Res Clin Pract. 2020. PMID: 32497744 Free PMC article. Review.
Cited by 6 articles
-
The effects of all trans retinoic acid, vitamin D3 and their combination on plasma levels of miRNA-125a-5p, miRNA-34a, and miRNA-126 in an experimental model of diabetes.Avicenna J Phytomed. 2022 Jan-Feb;12(1):67-76. doi: 10.22038/AJP.2021.18598. Avicenna J Phytomed. 2022. PMID: 35145896 Free PMC article.
-
HbA1c Screening for Diabetes in Patients with Acute Coronary Syndrome: A Worthwhile Test or a Pitfall?J Clin Med. 2021 Sep 23;10(19):4334. doi: 10.3390/jcm10194334. J Clin Med. 2021. PMID: 34640351 Free PMC article.
-
Standardizing the haemoglobin glycation index.Endocrinol Diabetes Metab. 2021 Oct;4(4):e00299. doi: 10.1002/edm2.299. Epub 2021 Sep 23. Endocrinol Diabetes Metab. 2021. PMID: 34558807 Free PMC article.
-
HbA1c Is Disproportionately Higher in Women and Older People With Type 1 Diabetes Compared With Flash Glucose Monitoring Metrics of Glycemic Control.J Diabetes Sci Technol. 2022 Mar;16(2):446-453. doi: 10.1177/1932296820967335. Epub 2020 Oct 26. J Diabetes Sci Technol. 2022. PMID: 33100062 Free PMC article.
-
Consistency of the Glycation Gap with the Hemoglobin Glycation Index Derived from a Continuous Glucose Monitoring System.Endocrinol Metab (Seoul). 2020 Jun;35(2):377-383. doi: 10.3803/EnM.2020.35.2.377. Epub 2020 Jun 24. Endocrinol Metab (Seoul). 2020. PMID: 32615722 Free PMC article.
References
-
- American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018; 41 (Suppl.1): S55-S64.
-
- Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007; 167: 1545-1551.
-
- Hempe JM, Liu S, Myers L, McCarter RJ, Buse JB, Fonseca V. The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial. Diabetes Care 2015; 38: 1067-1074.
-
- Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care 2008; 31: 1473-1478.
-
- Bergenstal RM, Gal RL, Connor CG, Gubitosi-Klug R, Kruger D, Olson BA et al. Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels. Ann Intern Med 2017; 167: 95-102.
Publication types
MeSH terms
Substances
Grant support
- I01-BX003340/Atlanta VA Health Care System/International
- R21 DK099716/DK/NIDDK NIH HHS/United States
- PHILLI12A0/Cystic Fibrosis Foundation/International
- I01-CX001025/Atlanta VA Health Care System/International
- National Science Foundation/International
- I01 CX001737/CX/CSRD VA/United States
- U34 DK091958/DK/NIDDK NIH HHS/United States
- R21 DK105891/DK/NIDDK NIH HHS/United States
- I01CX001737/Atlanta VA Health Care System/International
- U01 DK098246/NH/NIH HHS/United States
- R03 AI133172/NH/NIH HHS/United States
- UL1 TR002378/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous